TY - JOUR
T1 - Emergency Transthoracic Transapical Mitral Valve-in-Valve Implantation
AU - Van Garsse, Leen A. F. M.
AU - Gelsomino, Sandro
AU - van Ommen, Vincent
AU - Luca, Fabiana
AU - Maessen, Jos
PY - 2011/10
Y1 - 2011/10
N2 - Objectives: The valve-in-valve (VIV) technique is an emerging therapeutic option for patients with failure of previously implanted xenografts. We describe a balloon-expandable transthoracic transapical mitral VIV implantation in an emergency setting in a 69-year-old woman with dysfunction of the mitral bioprosthesis. Methods: Left ventricular apical access was applied. After balloon valvuloplasty, a 26-mm Edwards-Sapien transcatheter valve (Edwards Lifesciences LLC, Irvine, CA, USA) was deployed within the mitral xenograft, using rapid ventricular pacing. Results: The transcatheter valve functioned properly postoperatively and three-dimensional echocardiography carried out 1 month later showed a well-functioning VIV prosthesis and no mitral stenosis (mitral valve area 3 cm(2), mean gradient 3 mmHg). Conclusions: In this patient, VIV implantation was found to be a safe alternative to an emergent valve replacement. It might represent a suitable option to conventional procedures even among lower risk patients. (J Interven Cardiol 2011; 24:474-476)
AB - Objectives: The valve-in-valve (VIV) technique is an emerging therapeutic option for patients with failure of previously implanted xenografts. We describe a balloon-expandable transthoracic transapical mitral VIV implantation in an emergency setting in a 69-year-old woman with dysfunction of the mitral bioprosthesis. Methods: Left ventricular apical access was applied. After balloon valvuloplasty, a 26-mm Edwards-Sapien transcatheter valve (Edwards Lifesciences LLC, Irvine, CA, USA) was deployed within the mitral xenograft, using rapid ventricular pacing. Results: The transcatheter valve functioned properly postoperatively and three-dimensional echocardiography carried out 1 month later showed a well-functioning VIV prosthesis and no mitral stenosis (mitral valve area 3 cm(2), mean gradient 3 mmHg). Conclusions: In this patient, VIV implantation was found to be a safe alternative to an emergent valve replacement. It might represent a suitable option to conventional procedures even among lower risk patients. (J Interven Cardiol 2011; 24:474-476)
U2 - 10.1111/j.1540-8183.2011.00637.x
DO - 10.1111/j.1540-8183.2011.00637.x
M3 - Article
C2 - 21414030
SN - 0896-4327
VL - 24
SP - 474
EP - 476
JO - Journal of Interventional Cardiology
JF - Journal of Interventional Cardiology
IS - 5
ER -